Wenkai Jiang

6PUBLICATIONS
1CO-AUTHORS
Molecular targetsClinical pharmacology and therapeuticsTumour immunologyPredictive and prognostic markersPopulation trends and policies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 28, 2026
Resveratrol for Cancer Treatment: Effects on Metabolism and Immune Cells.

Rongrong Bao, Tianrui Wang, Wenkai Jiang

|Sep 28, 2024
Natural Compounds for the Treatment of Acute Pancreatitis: Novel Anti-Inflammatory Therapies.

Wenkai Jiang, Xiao Li, Yi Zhang

|Aug 26, 2023
Integration of Single-Cell RNA Sequencing and Bulk RNA Sequencing Reveals That TAM2-Driven Genes Affect Immunotherapeutic Response and Prognosis in Pancreatic Cancer.

Yan Du, Shi Dong, Wenkai Jiang

|Mar 29, 2023
Immunocyte Infiltration Analysis and Immunohistochemistry Identify EVL as a Potential Prognostic Biomarker for Pancreatic Cancer.

Yan Du, Lin Zhu, Xin Li

|Mar 29, 2023
Nomograms for Predicting the Risk and Prognosis of Liver Metastases in Pancreatic Cancer: A Population-Based Analysis.

Huaqing Shi, Xin Li, Zhou Chen

|Jan 21, 2023
The Global, Regional and National Burden of Pancreatic Cancer Attributable to Smoking, 1990 to 2019: A Systematic Analysis from the Global Burden of Disease Study 2019.

Wenkai Jiang, Caifei Xiang, Yan Du

Pageof 1

Frequent Collaborators

2 joint publications

Wence Zhou